+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bloodstream Infection Testing Market - Global Forecast 2026-2032- Product Image
Bloodstream Infection Testing Market - Global Forecast 2026-2032- Product Image
New

Bloodstream Infection Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977727
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bloodstream infection testing market is navigating rapid technology advances and evolving clinical expectations, driving change across diagnostic solutions and procurement strategies for healthcare organizations.

Market Snapshot: Bloodstream Infection Testing Market Size & Growth

The Bloodstream Infection Testing Market grew from USD 1.30 billion in 2025 to USD 1.39 billion in 2026 and is expected to continue growing at a CAGR of 7.93%, reaching USD 2.22 billion by 2032. This expansion reflects robust demand for faster, more accurate, and interoperable diagnostic tools as global health systems respond to persistent clinical urgency for improved sepsis management and patient outcomes.

Scope & Segmentation

This report delivers a comprehensive perspective across critical segments, product types, and global regions influencing the market landscape:

  • Product Types: Instruments for rapid identification and advanced connectivity; reagents and kits as core consumables for routine and complex assays; software solutions to enhance clinical workflows and decision support.
  • Technological Modalities: Biosensor platforms leveraging electrochemical and optical detection for point-of-care use; automated culture-based systems; mass spectrometry tools, notably MALDI-ToF, streamlining organism recognition; molecular diagnostics enabling targeted pathogen identification and resistance profiling.
  • End User Needs: Academic and research institutions focused on translational advancements and method validation; hospital laboratories integrating rapid diagnostics within treatment pathways; point-of-care settings requiring portability and ease for bedside triage; reference laboratories delivering specialized testing for complex confirmations.
  • Application Priorities: Immediate clinical diagnosis, research applications driving innovation, and surveillance efforts supporting public health and antimicrobial stewardship.
  • Key Regions: Americas emphasizing EHR integration and value-based procurement; Europe, Middle East, and Africa featuring varied adoption influenced by healthcare infrastructure and reimbursement; Asia-Pacific reflecting manufacturing strengths and diverse uptake supported by regulatory harmonization.

Key Takeaways

  • Diagnostic innovation is shifting from purely improving sensitivity to offering actionable speed and seamless point-of-care integration, optimizing treatment pathways and clinical outcomes.
  • Laboratory stakeholders are balancing the demands of automation, quality control, and cost management, underscoring the need for configurable solutions matched to workflow realities and accreditation standards.
  • Procurement priorities now emphasize total cost transparency and supply resilience, especially in response to evolving trade policy and logistics challenges.
  • Collaborative ecosystem strategies—integrating instruments, consumables, and digital platforms—support sustainable differentiation in a competitive landscape.
  • Regional distinctions in reimbursement and healthcare infrastructure shape technology adoption, requiring tailored go-to-market and service models for sustained growth.
  • Effective diagnostic adoption increasingly depends on transparent supplier relationships, real-time digital connectivity, and data-driven evidence for clinical utility.

Tariff Impact on Supply Chains & Procurement

Recent tariff and trade policy shifts have accelerated strategic sourcing changes for manufacturers and buyers alike. Organizations are mitigating cost volatility by diversifying suppliers, building longer-term agreements, and increasing critical stockpiles. These adaptations affect inventory management, production continuity, and working capital needs, with downstream implications for laboratory operations and total diagnostic solution pricing. Enhanced collaboration between manufacturers, distributors, and logistics partners is now essential for seamless test availability and operational resilience.

Methodology & Data Sources

Findings are based on a mixed-methods approach integrating primary interviews with laboratory directors, infectious disease specialists, procurement leaders, and product developers. Insights were triangulated with peer-reviewed clinical literature, regulatory documentation, technical white papers, and corporate disclosures. Systematic analysis and peer review ensured credible, actionable intelligence for practitioner-led decision making.

Why This Report Matters

  • Enables senior decision-makers to benchmark evolving technologies and operational models against market trends and emerging clinical requirements.
  • Supports strategic planning, procurement, and risk management by illuminating region-specific adoption drivers and tariff-linked supply chain impacts.
  • Delivers actionable insights for aligning product development, partnerships, and commercialization with real-world healthcare needs.

Conclusion

The bloodstream infection testing market is experiencing purposeful change, driven by technology convergence and clinical demand for actionable, integrated solutions. Leaders that align product capabilities, supply resilience, and service quality with healthcare priorities are best positioned to advance diagnostic adoption and improve patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bloodstream Infection Testing Market, by Product
8.1. Instruments
8.2. Reagents & Kits
8.3. Software
9. Bloodstream Infection Testing Market, by Technology
9.1. Biosensor Platforms
9.1.1. Electrochemical Biosensors
9.1.2. Optical Biosensors
9.2. Culture Based Systems
9.2.1. Automated Culture Systems
9.2.2. Manual Culture Methods
9.3. Mass Spectrometry
9.4. Molecular Diagnostics
9.4.1. Next Generation Sequencing
9.4.2. PCR
10. Bloodstream Infection Testing Market, by Application
10.1. Clinical Diagnosis
10.2. Research
10.3. Surveillance & Monitoring
11. Bloodstream Infection Testing Market, by End User
11.1. Academic & Research Institutes
11.2. Hospital Laboratories
11.3. Point Of Care Testing
11.4. Reference Laboratories
12. Bloodstream Infection Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Bloodstream Infection Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bloodstream Infection Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Bloodstream Infection Testing Market
16. China Bloodstream Infection Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Accelerate Diagnostics, Inc.
17.7. Beckman Coulter, Inc.
17.8. Becton, Dickinson and Company
17.9. Bio-Rad Laboratories, Inc.
17.10. bioMérieux SA
17.11. Bruker Corporation
17.12. Cepheid
17.13. Danaher Corporation
17.14. DiaSorin S.p.A.
17.15. F. Hoffmann-La Roche AG
17.16. Grifols S.A.
17.17. Hardy Diagnostics
17.18. HiMedia Laboratories Pvt. Ltd.
17.19. Hologic, Inc.
17.20. Luminex Corporation
17.21. Meridian Bioscience, Inc.
17.22. Molzym
17.23. OpGen, Inc.
17.24. Qiagen N.V.
17.25. Siemens Healthineers AG
17.26. Sysmex Corporation
17.27. T2 Biosystems, Inc.
17.28. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ELECTROCHEMICAL BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ELECTROCHEMICAL BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ELECTROCHEMICAL BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY OPTICAL BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY OPTICAL BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY OPTICAL BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MANUAL CULTURE METHODS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MANUAL CULTURE METHODS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MANUAL CULTURE METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SURVEILLANCE & MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SURVEILLANCE & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SURVEILLANCE & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 104. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 106. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 120. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 122. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 123. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 124. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 137. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 139. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 140. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 141. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. ASEAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 145. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 147. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 148. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 149. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. GCC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 161. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 163. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 164. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 165. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. BRICS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 169. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 171. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 172. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 173. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. G7 BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 179. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 180. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 181. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. NATO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 194. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BIOSENSOR PLATFORMS, 2018-2032 (USD MILLION)
TABLE 196. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY CULTURE BASED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 197. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 198. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Bloodstream Infection Testing market report include:
  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bruker Corporation
  • Cepheid
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Grifols S.A.
  • Hardy Diagnostics
  • HiMedia Laboratories Pvt. Ltd.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Molzym
  • OpGen, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.39 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.22 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Bloodstream Infection Testing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Bloodstream Infection Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Bloodstream Infection Testing - Global Strategic Business Report - Product Image

Bloodstream Infection Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Blood Stream Infection Testing Market Report 2025 - Product Image

Blood Stream Infection Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Blood Culture Test - A Global Market Overview - Product Image

Blood Culture Test - A Global Market Overview

  • Report
  • 405 Pages
  • Global
From
Blood Culture Test Market Size, Share, Trends and Forecast by Testing Method, Product, Technology, Application, End User, and Region, 2025-2033 - Product Image

Blood Culture Test Market Size, Share, Trends and Forecast by Testing Method, Product, Technology, Application, End User, and Region, 2025-2033

  • Report
  • 138 Pages
  • Global
From

About the Bloodstream Infection Test Market

The Bloodstream Infection Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of bacteria, fungi, and viruses in the bloodstream. The test is typically performed on a sample of blood taken from a patient, and the results are used to diagnose and treat infections. The test can also be used to monitor the effectiveness of treatments. The Bloodstream Infection Test market is highly competitive, with a range of products available from different manufacturers. These products vary in terms of accuracy, cost, and turnaround time. The market is also subject to regulatory requirements, which can affect the availability of certain products. Some companies in the Bloodstream Infection Test market include Abbott, Becton Dickinson, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.